Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Erythroblastosis, Fetal MeSH Descriptor Data 2026


MeSH Heading
Erythroblastosis, Fetal
Tree Number(s)
C12.050.703.277.060
C15.378.295
C16.300.060
C16.614.304
C20.306
Unique ID
D004899
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D004899
Annotation
erythroblastosis, non-fetal may be ERYTHREMIC MYELOSIS but be careful; do not confuse with VITAMIN K DEFICIENCY BLEEDING
Scope Note
A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN.
Entry Term(s)
Erythroblastosis Fetalis
Hemolytic Disease of Newborn
NLM Classification #
WH 425
See Also
Jaundice, Neonatal
Date Introduced
1966/01/01
Last Updated
2021/06/30
Erythroblastosis, Fetal Preferred
page delivered in 0.184s